Tower Research Capital LLC (Trc) Avenue Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.22 - $0.56 $6,365 - $16,202	-28,933 Reduced 90.22%	3,135 $1,000
Q1 2022 May 12, 2022	BUY	$0.22 - $0.96 $2,318 - $10,116	10,538 Added 48.95%	32,068 $15,000
Q4 2021 Feb 14, 2022	BUY	$0.88 - $1.78 $4,246 - $8,590	4,826 Added 28.89%	21,530 $19,000
Q3 2021 Nov 15, 2021	BUY	$1.48 - $2.65 $7,889 - $14,127	5,331 Added 46.87%	16,704 $25,000
Q2 2021 Aug 16, 2021	BUY	$2.41 - $7.11 $20,639 - $60,890	8,564 Added 304.88%	11,373 $29,000
Q1 2021 May 17, 2021	SELL	$4.7 - $7.17 $25,441 - $38,811	-5,413 Reduced 65.84%	2,809 $17,000
Q4 2020 Feb 16, 2021	BUY	$2.95 - $11.04 $3,882 - $14,528	1,316 Added 19.06%	8,222 $49,000
Q3 2020 Nov 16, 2020	BUY	$9.37 - $12.06 $19,452 - $25,036	2,076 Added 42.98%	6,906 $75,000
Q2 2020 Aug 13, 2020	BUY	$8.29 - $11.47 $38,871 - $53,782	4,689 Added 3325.53%	4,830 $52,000
Q1 2020 May 15, 2020	BUY	$6.44 - $11.32 $908 - $1,596	141 New	141 $1,000
Q2 2019 Aug 13, 2019	SELL	$4.33 - $6.54 $1,766 - $2,668	-408 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$4.75 - $6.59 $1,938 - $2,688	408 New	408 $2,000
Q3 2018 Nov 13, 2018	SELL	$2.75 - $4.21 $1,721 - $2,635	-626 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$3.58 - $4.96 $2,241 - $3,104	626 New	626 $2,000
Q4 2017 Feb 09, 2018	SELL	$3.53 - $5.64 $25,857 - $41,313	-7,325 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.08 - $6.68 $37,211 - $48,931	7,325	7,325 $41,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $9.25M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.